Discover ALPCO’s novel automated nontreponemal immunoassay for syphilis testing. Reduce subjectivity, improve workflow efficiency, and support faster treatment decisions.
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
June 7, 2025 - Cambridge, MA – TEAM ALPCO proudly partnered with the Crohn’s & Colitis Foundation for their signature fundraising event, Take Steps: One Step Closer to Cures. This inspiring walk united communities and advocates to raise vital funds for research, education, support, and advocacy for those affected by Inflammatory Bowel Disease (IBD).
We’re excited to be exhibiting at this year’s ADLM Exposition, stop by Booth #3245 to explore our innovative, cutting-edge technology solutions designed to meet your research needs.
SALEM, NH, May 5th, 2025 – American Laboratory Products Company, Ltd. (“ALPCO”), a global provider of specialty diagnostic solutions, announced the European commercial launch of its Calprotectin Immunoturbidimetric Assay, expanding its portfolio of gastrointestinal (GI) diagnostic solutions globally.
As the exclusive North American distributor for Macro Array Diagnostics (MADx), ALPCO is excited to participate in the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting in in San Diego, CA.
Salem, NH, April 25, 2024 – Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This collaboration brings together EUROIMMUN’s extensive distribution network and support infrastructure with ALPCO-GeneProof's innovative molecular diagnostic technologies.
As the exclusive North American distributor for Macro Array Diagnostics (MADx), ALPCO is excited to participate in the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC.
Salem, NH, December 19, 2023 – American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic solutions.
